The global Metabolic Disorders Drugs market is expected to reach USD xx Million by 2030, according to a new report by JC MARKET RESEARCH. The report provides an in-depth analysis of the Metabolic Disorders Drugs market, including its drivers, restraints, opportunities, and challenges. It also segments the market on the basis of type, application, and geography.
The report offers a detailed overview of the market dynamics that are expected to impact the market during the forecast period. It also provides an assessment of the key trends that are currently shaping the market. Moreover, the report profiles the leading players in the market and provides a detailed analysis of their business strategies.
Key Market Players:
Zealand Pharma
Rhythm
OxThera
Biophytis
Biophytis
Zafgen
PerkinElmer
Eternygen
Pronutria Biosciences
MedGenome
CellCentric
Nimbus Therapeutics
Mitobridge
Exelixis, Inc.
Outpost Medicine
Anchor Therapeutics
Verva Pharmaceuticals
Global Metabolic Disorders Drugs Маrkеt Ѕеgmеntаtіоn:
Market By Type
- Tablet
- Injection
Based on the end-use, the global Metabolic Disorders Drugs market classified into
- Diabetes
- Disorders of the Thyroid and Pituitary Gland
- Others
Global Metabolic Disorders Drugs Market: Regional Analysis
North America
Europe
Asia Pacific
Rest of the World
The report provides a detailed competitive landscape of the market, with the help of company profiles and SWOT analysis of the leading players.
Chapter 1 Global Metabolic Disorders Drugs Market Overview
1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Metabolic Disorders Drugs Market
1.4 Restraints for Metabolic Disorders Drugs Market
1.5 Opportunities for Metabolic Disorders Drugs Market
1.6 Trends for Metabolic Disorders Drugs Market
1.7 COVID-19 Impact Assessment on Metabolic Disorders Drugs Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis
Chapter 2 Global Metabolic Disorders Drugs Market Overview
2.1 Global Metabolic Disorders Drugs Market by Product Type
2.1.1 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2030)
2.1.2 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Metabolic Disorders Drugs Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Metabolic Disorders Drugs Market by End User
2.2.1 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2030)
2.2.2 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Metabolic Disorders Drugs Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Metabolic Disorders Drugs Market by Region
2.3.1 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2030)
2.3.2 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Metabolic Disorders Drugs Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Metabolic Disorders Drugs Market Outlook (2013-2030)
2.4.1 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2022-2030)
2.5 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2022-2030)
2.6 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2022-2030)
2.7 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2022-2030)
2.8 Global Metabolic Disorders Drugs Market Y-o-Y Growth Rate Comparison (2014-2030)
2.8.1 Global Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Region
2.8.2 Global Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Metabolic Disorders Drugs Market Y-o-Y Growth Rate by End User
2.9 Global Metabolic Disorders Drugs Market Share Comparison (2013-2030)
2.9.1 Global Metabolic Disorders Drugs Market Share by Region
2.9.2 Global Metabolic Disorders Drugs Market Share by Product Type
2.9.3 Global Metabolic Disorders Drugs Market Share by End User
Chapter 3 North America Metabolic Disorders Drugs Market Overview
3.1 North America Metabolic Disorders Drugs Market by Product Type
3.1.1 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2030)
3.1.2 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Metabolic Disorders Drugs Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Metabolic Disorders Drugs Market by End User
3.2.1 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2030)
3.2.2 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Metabolic Disorders Drugs Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Metabolic Disorders Drugs Market by Region
3.3.1 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2030)
3.3.2 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Metabolic Disorders Drugs Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Metabolic Disorders Drugs Market Outlook (2013-2030)
3.4.1 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2022-2030)
3.5 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2022-2030)
3.6 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2022-2030)
3.7 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2022-2030)
3.8 North America Metabolic Disorders Drugs Market Y-o-Y Growth Rate Comparison (2014-2030)
3.8.1 North America Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Region
3.8.2 North America Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Metabolic Disorders Drugs Market Y-o-Y Growth Rate by End User
3.9 North America Metabolic Disorders Drugs Market Share Comparison (2013-2030)
3.9.1 North America Metabolic Disorders Drugs Market Share by Region
3.9.2 North America Metabolic Disorders Drugs Market Share by Product Type
3.9.3 North America Metabolic Disorders Drugs Market Share by End User
Chapter 4 Europe Metabolic Disorders Drugs Market Overview
4.1 Europe Metabolic Disorders Drugs Market by Product Type
4.1.1 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2030)
4.1.2 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Metabolic Disorders Drugs Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Metabolic Disorders Drugs Market by End User
4.2.1 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2030)
4.2.2 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Metabolic Disorders Drugs Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Metabolic Disorders Drugs Market by Region
4.3.1 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2030)
4.3.2 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Metabolic Disorders Drugs Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Metabolic Disorders Drugs Market Outlook (2013-2030)
4.4.1 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2022-2030)
4.5 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2022-2030)
4.6 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2022-2030)
4.7 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2022-2030)
4.8 Europe Metabolic Disorders Drugs Market Y-o-Y Growth Rate Comparison (2014-2030)
4.8.1 Europe Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Region
4.8.2 Europe Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Metabolic Disorders Drugs Market Y-o-Y Growth Rate by End User
4.9 Europe Metabolic Disorders Drugs Market Share Comparison (2013-2030)
4.9.1 Europe Metabolic Disorders Drugs Market Share by Region
4.9.2 Europe Metabolic Disorders Drugs Market Share by Product Type
4.9.3 Europe Metabolic Disorders Drugs Market Share by End User
Chapter 5 Asia Pacific Metabolic Disorders Drugs Market Overview
5.1 Asia Pacific Metabolic Disorders Drugs Market by Product Type
5.1.1 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2030)
5.1.2 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Metabolic Disorders Drugs Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Metabolic Disorders Drugs Market by End User
5.2.1 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2030)
5.2.2 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Metabolic Disorders Drugs Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Metabolic Disorders Drugs Market by Region
5.3.1 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2030)
5.3.2 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Metabolic Disorders Drugs Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Metabolic Disorders Drugs Market Outlook (2013-2030)
5.4.1 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2022-2030)
5.5 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2022-2030)
5.6 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2022-2030)
5.7 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2022-2030)
5.8 Asia Pacific Metabolic Disorders Drugs Market Y-o-Y Growth Rate Comparison (2014-2030)
5.8.1 Asia Pacific Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Metabolic Disorders Drugs Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Metabolic Disorders Drugs Market Share Comparison (2013-2030)
5.9.1 Asia Pacific Metabolic Disorders Drugs Market Share by Region
5.9.2 Asia Pacific Metabolic Disorders Drugs Market Share by Product Type
5.9.3 Asia Pacific Metabolic Disorders Drugs Market Share by End User
Chapter 6 South America Metabolic Disorders Drugs Market Overview
6.1 South America Metabolic Disorders Drugs Market by Product Type
6.1.1 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2030)
6.1.2 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Metabolic Disorders Drugs Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Metabolic Disorders Drugs Market by End User
6.2.1 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2030)
6.2.2 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Metabolic Disorders Drugs Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Metabolic Disorders Drugs Market by Region
6.3.1 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2030)
6.3.2 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Metabolic Disorders Drugs Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Metabolic Disorders Drugs Market Outlook (2013-2030)
6.4.1 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2022-2030)
6.5 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2022-2030)
6.6 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2022-2030)
6.7 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2022-2030)
6.8 South America Metabolic Disorders Drugs Market Y-o-Y Growth Rate Comparison (2014-2030)
6.8.1 South America Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Region
6.8.2 South America Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Metabolic Disorders Drugs Market Y-o-Y Growth Rate by End User
6.9 South America Metabolic Disorders Drugs Market Share Comparison 2013-2030
6.9.1 South America Metabolic Disorders Drugs Market Share by Region
6.9.2 South America Metabolic Disorders Drugs Market Share by Product Type
6.9.3 South America Metabolic Disorders Drugs Market Share by End User
Chapter 7 MEA Metabolic Disorders Drugs Market Overview
7.1 MEA Metabolic Disorders Drugs Market by Product Type
7.1.1 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2030)
7.1.2 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Metabolic Disorders Drugs Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Metabolic Disorders Drugs Market by End User
7.2.1 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2030)
7.2.2 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Metabolic Disorders Drugs Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Metabolic Disorders Drugs Market by Region
7.3.1 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2030)
7.3.2 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Metabolic Disorders Drugs Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Metabolic Disorders Drugs Market Outlook (2013-2030)
7.4.1 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) (2022-2030)
7.5 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Region (2022-2030)
7.6 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2022-2030)
7.7 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Metabolic Disorders Drugs Market Value (US$ Mn) and Volume (Units) Comparison by End User (2022-2030)
7.8 MEA Metabolic Disorders Drugs Market Y-o-Y Growth Rate Comparison (2014-2030)
7.8.1 MEA Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Region
7.8.2 MEA Metabolic Disorders Drugs Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Metabolic Disorders Drugs Market Y-o-Y Growth Rate by End User
7.9 MEA Metabolic Disorders Drugs Market Share Comparison (2013-2030)
7.9.1 MEA Metabolic Disorders Drugs Market Share by Region
7.9.2 MEA Metabolic Disorders Drugs Market Share by Product Type
7.9.3 MEA Metabolic Disorders Drugs Market Share by End User
Chapter 8 Global Metabolic Disorders Drugs Market Company Profiles
8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis
Companies Included:
Zealand Pharma
Rhythm
OxThera
Biophytis
Biophytis
Zafgen
PerkinElmer
Eternygen
Pronutria Biosciences
MedGenome
CellCentric
Nimbus Therapeutics
Mitobridge
Exelixis, Inc.
Outpost Medicine
Anchor Therapeutics
Verva Pharmaceuticals
Chapter 9 Methodology and Data Source
9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources
